PAVmed, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.62%612.171.0%$694.47m
DHRDanaher Corp. 0.90%313.520.7%$689.48m
ABTAbbott Laboratories 1.39%126.790.8%$672.08m
MDTMedtronic Plc 1.13%123.020.6%$552.77m
ISRGIntuitive Surgical, Inc. 0.56%341.520.8%$438.08m
ALGNAlign Technology, Inc. -1.49%590.566.3%$335.66m
BDXBecton, Dickinson & Co. 0.28%247.171.0%$300.19m
DXCMDexCom, Inc. -0.27%566.577.8%$274.45m
SYKStryker Corp. -0.19%275.911.3%$272.46m
EWEdwards Lifesciences Corp. 0.76%116.620.4%$266.76m
BSXBoston Scientific Corp. -0.11%44.821.0%$249.23m
AAgilent Technologies, Inc. 0.60%157.881.6%$217.19m
IDXXIDEXX Laboratories, Inc. 1.02%651.853.8%$213.59m
BAXBaxter International, Inc. 0.90%82.191.8%$187.14m
INMDInMode Ltd. 0.64%84.480.0%$180.38m

Company Profile

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: GI Health, Minimally Invasive Interventions, Infusion Therapy, and Emerging Innovations. The GI health division comprises of EsoGuard esophageal DNA laboratory developed test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus technology. The minimally invasive interventions division offers CarpX minimally invasive surgical device for carpal tunnel syndrome. The infusion therapy division includes PortIO implantable intraosseous vascular accedd device and NextFlo highly accurate disposable intravenous infusion platform technology. The emerging innovations divisions consists of non-invasive laser-based glucose monitoring, single-use ventilators, resorbable pediatric ear tubes and mechanical circulatory cannulas. The company was founded on June 26, 2014 and is headquartered in New York, NY.